AFP and hepatocellular carcinoma: The results above show that the ability of AFP‐L3% is not beneficial to AFP, which is in agreement with the results of previous studies28, 29; moreover, the use of AFP in combination with AFP‐L3% did not enhance the accuracy of distinguishing between subjects with and without HCC.